Sompo Asset Management Co., Ltd. Gilead Sciences, Inc. Transaction History

Sompo Asset Management Co., Ltd.

$635 Million
Q3 2024

A detailed history of Sompo Asset Management Co., Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Sompo Asset Management Co., Ltd. holds 5,660 shares of GILD stock, worth $510,475. This represents 0.07% of its overall portfolio holdings.

Number of Shares

5,660

Previous 4,890 15.75%

Holding current value

$510,475

Previous $335,000 41.49%

% of portfolio

0.07%

Previous 0.06%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$66.59 - $83.99 $51,274 - $64,672	770 Added 15.75%	5,660 $474,000
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $13,893 - $16,033	-220 Reduced 4.31%	4,890 $335,000
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $409,437 - $499,298	-5,720 Reduced 52.82%	5,110 $374,000
Q4 2023 Feb 13, 2024	BUY	$73.27 - $83.09 $136,282 - $154,547	1,860 Added 20.74%	10,830 $877,000
Q3 2023 Nov 09, 2023	SELL	$73.94 - $80.67 $36,230 - $39,528	-490 Reduced 5.18%	8,970 $672,000
Q2 2023 Aug 10, 2023	SELL	$76.01 - $86.7 $1.15 Million - $1.31 Million	-15,070 Reduced 61.43%	9,460 $729,000
Q1 2023 May 09, 2023	SELL	$77.31 - $88.08 $1.72 Million - $1.96 Million	-22,250 Reduced 47.56%	24,530 $2.04 Million
Q4 2022 Feb 01, 2023	SELL	$62.32 - $89.47 $1.56 Million - $2.24 Million	-25,030 Reduced 34.86%	46,780 $4.02 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $873,451 - $997,706	14,670 Added 25.67%	71,810 $4.43 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $2.52 Million - $2.84 Million	43,740 Added 326.42%	57,140 $3.53 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $93,830 - $117,579	-1,620 Reduced 10.79%	13,400 $796,000
Q4 2021 Feb 11, 2022	BUY	$64.88 - $73.64 $227,728 - $258,476	3,510 Added 30.5%	15,020 $1.09 Million
Q3 2021 Nov 09, 2021	SELL	$67.69 - $73.03 $129,964 - $140,217	-1,920 Reduced 14.3%	11,510 $803,000
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $109,168 - $119,281	1,720 Added 14.69%	13,430 $925,000
Q1 2021 May 14, 2021	SELL	$60.0 - $68.46 $113,400 - $129,389	-1,890 Reduced 13.9%	11,710 $757,000
Q3 2020 Nov 06, 2020	SELL	$62.1 - $78.08 $3,726 - $4,684	-60 Reduced 0.44%	13,600 $859,000
Q2 2020 Aug 05, 2020	SELL	$72.34 - $84.0 $1.58 Million - $1.84 Million	-21,860 Reduced 61.54%	13,660 $1.05 Million
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $311,271 - $398,693	-4,970 Reduced 12.27%	35,520 $2.66 Million
Q4 2019 Feb 10, 2020	BUY	$61.62 - $67.78 $2.49 Million - $2.74 Million	40,490 New	40,490 $2.63 Million

Others Institutions Holding GILD

# of Institutions

1,923

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sompo Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sompo Asset Management Co., Ltd. with notifications on news.

Account

Sompo Asset Management Co., Ltd. Gilead Sciences, Inc. Transaction History